The Kaplan-Meier survival curve analysis further revealed that CRC patients with a high DLX5 expression level had a poor survival rate (Fig. 3B), thus confirming that DLX5 could be a potential adverse prognostic marker. Here, DLX5 is linked to colorectal carcinoma.